Anti-Pseudomonas aeruginosa activity of natural antimicrobial peptides when used alone or in combination with antibiotics

The World Health Organization has recently published a list of 12 drug-resistant bacteria that posed a significant threat to human health, and Pseudomonas aeruginosa (P. aeruginosa) was among them. In China, P. aeruginosa is a common pathogen in hospital acquired pneumonia, accounting for 16.9–22.0%...

Full description

Bibliographic Details
Main Authors: Xueqi Chen, Shan Su, Yan Yan, Limei Yin, Lihong Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2023.1239540/full
_version_ 1797692438636134400
author Xueqi Chen
Shan Su
Yan Yan
Limei Yin
Lihong Liu
author_facet Xueqi Chen
Shan Su
Yan Yan
Limei Yin
Lihong Liu
author_sort Xueqi Chen
collection DOAJ
description The World Health Organization has recently published a list of 12 drug-resistant bacteria that posed a significant threat to human health, and Pseudomonas aeruginosa (P. aeruginosa) was among them. In China, P. aeruginosa is a common pathogen in hospital acquired pneumonia, accounting for 16.9–22.0%. It is a ubiquitous opportunistic pathogen that can infect individuals with weakened immune systems, leading to hospital-acquired acute and systemic infections. The excessive use of antibiotics has led to the development of various mechanisms in P. aeruginosa to resist conventional drugs. Thus, there is an emergence of multidrug-resistant strains, posing a major challenge to conventional antibiotics and therapeutic approaches. Antimicrobial peptides are an integral component of host defense and have been found in many living organisms. Most antimicrobial peptides are characterized by negligible host toxicity and low resistance rates, making them become promising for use as antimicrobial products. This review particularly focuses on summarizing the inhibitory activity of natural antimicrobial peptides against P. aeruginosa planktonic cells and biofilms, as well as the drug interactions when these peptides used in combination with conventional antibiotics. Moreover, the underlying mechanism of these antimicrobial peptides against P. aeruginosa strains was mainly related to destroy the membrane structure through interacting with LPS or increasing ROS levels, or targeting cellular components, leaded to cell lysis. Hopefully, this analysis will provide valuable experimental data on developing novel compounds to combat P. aeruginosa.
first_indexed 2024-03-12T02:28:37Z
format Article
id doaj.art-0967562b6fb340aa826a5d9bb5dece82
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-03-12T02:28:37Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-0967562b6fb340aa826a5d9bb5dece822023-09-05T10:28:41ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2023-09-011410.3389/fmicb.2023.12395401239540Anti-Pseudomonas aeruginosa activity of natural antimicrobial peptides when used alone or in combination with antibioticsXueqi Chen0Shan Su1Yan Yan2Limei Yin3Lihong Liu4Department of Pharmacy, China-Japan Friendship Hospital, Beijing, ChinaDepartment of Pharmacy, The Affiliated Taian City Central Hospital of Qingdao University, Taian, ChinaDepartment of Pharmacy, China-Japan Friendship Hospital, Beijing, ChinaDepartment of Pharmacy, China-Japan Friendship Hospital, Beijing, ChinaDepartment of Pharmacy, China-Japan Friendship Hospital, Beijing, ChinaThe World Health Organization has recently published a list of 12 drug-resistant bacteria that posed a significant threat to human health, and Pseudomonas aeruginosa (P. aeruginosa) was among them. In China, P. aeruginosa is a common pathogen in hospital acquired pneumonia, accounting for 16.9–22.0%. It is a ubiquitous opportunistic pathogen that can infect individuals with weakened immune systems, leading to hospital-acquired acute and systemic infections. The excessive use of antibiotics has led to the development of various mechanisms in P. aeruginosa to resist conventional drugs. Thus, there is an emergence of multidrug-resistant strains, posing a major challenge to conventional antibiotics and therapeutic approaches. Antimicrobial peptides are an integral component of host defense and have been found in many living organisms. Most antimicrobial peptides are characterized by negligible host toxicity and low resistance rates, making them become promising for use as antimicrobial products. This review particularly focuses on summarizing the inhibitory activity of natural antimicrobial peptides against P. aeruginosa planktonic cells and biofilms, as well as the drug interactions when these peptides used in combination with conventional antibiotics. Moreover, the underlying mechanism of these antimicrobial peptides against P. aeruginosa strains was mainly related to destroy the membrane structure through interacting with LPS or increasing ROS levels, or targeting cellular components, leaded to cell lysis. Hopefully, this analysis will provide valuable experimental data on developing novel compounds to combat P. aeruginosa.https://www.frontiersin.org/articles/10.3389/fmicb.2023.1239540/fullantimicrobial peptidesPseudomonas aeruginosaEscherichia colidrug resistancebiofilmsinteraction
spellingShingle Xueqi Chen
Shan Su
Yan Yan
Limei Yin
Lihong Liu
Anti-Pseudomonas aeruginosa activity of natural antimicrobial peptides when used alone or in combination with antibiotics
Frontiers in Microbiology
antimicrobial peptides
Pseudomonas aeruginosa
Escherichia coli
drug resistance
biofilms
interaction
title Anti-Pseudomonas aeruginosa activity of natural antimicrobial peptides when used alone or in combination with antibiotics
title_full Anti-Pseudomonas aeruginosa activity of natural antimicrobial peptides when used alone or in combination with antibiotics
title_fullStr Anti-Pseudomonas aeruginosa activity of natural antimicrobial peptides when used alone or in combination with antibiotics
title_full_unstemmed Anti-Pseudomonas aeruginosa activity of natural antimicrobial peptides when used alone or in combination with antibiotics
title_short Anti-Pseudomonas aeruginosa activity of natural antimicrobial peptides when used alone or in combination with antibiotics
title_sort anti pseudomonas aeruginosa activity of natural antimicrobial peptides when used alone or in combination with antibiotics
topic antimicrobial peptides
Pseudomonas aeruginosa
Escherichia coli
drug resistance
biofilms
interaction
url https://www.frontiersin.org/articles/10.3389/fmicb.2023.1239540/full
work_keys_str_mv AT xueqichen antipseudomonasaeruginosaactivityofnaturalantimicrobialpeptideswhenusedaloneorincombinationwithantibiotics
AT shansu antipseudomonasaeruginosaactivityofnaturalantimicrobialpeptideswhenusedaloneorincombinationwithantibiotics
AT yanyan antipseudomonasaeruginosaactivityofnaturalantimicrobialpeptideswhenusedaloneorincombinationwithantibiotics
AT limeiyin antipseudomonasaeruginosaactivityofnaturalantimicrobialpeptideswhenusedaloneorincombinationwithantibiotics
AT lihongliu antipseudomonasaeruginosaactivityofnaturalantimicrobialpeptideswhenusedaloneorincombinationwithantibiotics